When combined in a multivariate model with FIGO stage and surgical debulking, the most important clinical prognostic indicator of patient outcome in ovarian cancer, EDD expression, remained a significant predictor of disease recurrence (HR 2.25, P=0.0004; Table 3). Here, UBR5 is linked to ovarian cancer.